Embedded entrepreneur initiative (EEI)
Active Definitive Contract Awarded Last action
- Contract number
- HR001126CE019
- Awardee
-
Kairu Therapeutics Inc. UEI J3NYGMYBR6M5
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $350,000
Award facts
- Opportunity
-
- DARPA's Commercial Solutions Opening (DCSO) for Commercial Strategy Solicitation · HR001125RE003 · Posted May 1, 2025
- Contract value 100% obligated
- $350,000.00 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- B541 Special Studies/Analysis- Defense
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 15 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Alameda, CA 94501, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $350,000 |
About this award
The Defense Advanced Research Projects Agency awarded a $350,000 definitive contract to Kairu Therapeutics Inc. for the Embedded Entrepreneur Initiative on January 30, 2026, on a firm fixed price basis with no set-aside.
The Embedded Entrepreneur Initiative provides funding for organizations possessing technology derived from prior DARPA R&D efforts to hire external entrepreneurs to assist with commercialization. Eligible applicants must hold either direct DARPA contractor status or acquired rights to DARPA-derived technology. The originating solicitation, a Commercial Solutions Opening posted May 1, 2025 with rolling acceptance through April 30, 2026, evaluates proposals on potential contribution to DARPA's mission, commercialization readiness, and pricing. An amendment issued July 14, 2025 updated proposal requirements for all submissions after that date. The comprehensive framework encompasses 14 primary task areas including competitive analysis, financing plans, market engagement strategies, and regulatory compliance activities. Place of performance is Alameda, CA. The contract ceiling is $350,000 with an ultimate completion date of January 29, 2027.
Quick answers
Who was awarded contract HR001126CE019?
HR001126CE019 was awarded to Kairu Therapeutics Inc. by Defense Advanced Research Projects Agency (Department of Defense) on January 30, 2026.
How much is contract HR001126CE019 worth?
The government has obligated $350,000 on HR001126CE019.
Was contract HR001126CE019 competed?
The extent of competition for HR001126CE019 was competed under sap. The government received 15 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award